Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2009 - 2026)

Charles River Laboratories International has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $67.3 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 43.69% year-over-year to $67.3 million in Q2 2026; TTM through Jun 2026 was $297.9 million, a 30.75% decrease from a year earlier, with the FY2025 full-year figure at $403.3 million, up 11.49% from the prior year.
• Depreciation & Amortization (CF) was $67.3 million for Q2 2026 at Charles River Laboratories International, roughly flat from $67.2 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $120.4 million in Q1 2025, with the low at $67.2 million in Q1 2026.
• Average Depreciation & Amortization (CF) over 5 years is $84.3 million, with a median of $78.6 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) surged 41.01% in 2025, then sank 44.21% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $77.5 million in 2022, then increased by 3.83% to $80.5 million in 2023, then increased by 26.82% to $102.1 million in 2024, then dropped by 23.34% to $78.3 million in 2025, then slipped by 14.04% to $67.3 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $67.3 million (Q2 2026), $67.2 million (Q1 2026), and $78.3 million (Q4 2025), per Business Quant data.